Compound ID | 1410
Synonym(s): R207910
Class: Diarylquinoline
Details of activity: | Mycobacterium abscessus. Used to treat active tuberculosis |
Institute where first reported: | Janssen Pharmaceutica, Belgium |
Year first mentioned: | 2004 |
Highest developmental phase: | Approved by FDA in 2012 |
Development status: | Approved |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5388906 |
Guide to Pharmacology: | bedaquiline |
Citation: | https://aac.asm.org/content/63/8/e00827-19 |